Suven Life Sciences Ltd. — Regulatory Filings 2026

==> picture [112 x 56] intentionally omitted <==

CSD/BSE&NSE/ Surveillance/2026-27 Date: April 8, 2026

To

To

Department of Corporate Services BSE Limited 25th Floor, P. J. Towers, Dalal Street, Mumbai - 400001 Scrip Code: 530239

Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex Bandra (E), Mumbai – 400051

Scrip Symbol: SUVEN

Dear Sir/Madam,

Sub: Clarification on Price Movement

Ref: NSE/CM/Surveillance/16665, email dated 07/04/2026 BSE- L/SURV/ONL/PV/SJ/2026-2027/3515, email dated 07/04/2026

With reference to above mentioned subject, this is to inform that the Company has been notifying to the stock exchanges all the events, information which comes under the purview of Regulation 30 of SEBI (LODR) Regulations, 2015 from time to time.

At this point of time we do not have any material announcement/ event due for notification to the stock exchanges under Regulation 30 of SEBI (LODR) Regulations, 2015 which may have a bearing on the price or volume behavior of the scrip. The Movement in the price/volume of our security in the recent past appears to be based on market speculation and we have no other comment to offer on this development.

We request you to disseminate this clarification on your website for information of general public, which is also being uploaded on our Company’s website.

Thanking you. Yours faithfully,

For Suven Life Sciences Limited

SANGEETHA Digitally signed by SANGEETHA LAXMI KANDARI LAXMI KANDARI Date: 2026.04.08 10:18:48 +05'30' K. Sangeetha Laxmi Company Secretary

Suven Life Sciences Limited

Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: [email protected] website: www.suven.com